10 Dec Braeburn Announces Arbitration Determination that It Did Not Materially Breach Its License Agreement with Camurus AB
Plymouth Meeting, Pa. – December 10, 2020 – Braeburn announces that a tribunal appointed by the ICC International Court of Arbitration decided that Braeburn did not materially breach its license agreement with Camurus for the development and commercialization of an extended-release buprenorphine subcutaneous injection product. As a result of this...